Cytotech55,
Buy out? Why all this misbegotten fear? Poet’s management would be fools to accept a BO, if we’ve got the goods. If we don’t have a disruptive product, if the Interposer is a plain vanilla solution, then management will go with a buy out. That’s it for me.
I'd like to put out this fire, because talking of a BO just seems sooo... extremely premature. Everybody concerned over this issue should take a break from their screens. TMI